BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 9582341)

  • 1. X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution.
    Seetharaman J; Kanigsberg A; Slaaby R; Leffler H; Barondes SH; Rini JM
    J Biol Chem; 1998 May; 273(21):13047-52. PubMed ID: 9582341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition.
    Nagae M; Nishi N; Murata T; Usui T; Nakamura T; Wakatsuki S; Kato R
    J Biol Chem; 2006 Nov; 281(47):35884-93. PubMed ID: 16990264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography.
    Hirabayashi J; Hashidate T; Arata Y; Nishi N; Nakamura T; Hirashima M; Urashima T; Oka T; Futai M; Muller WE; Yagi F; Kasai K
    Biochim Biophys Acta; 2002 Sep; 1572(2-3):232-54. PubMed ID: 12223272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins.
    Leonidas DD; Elbert BL; Zhou Z; Leffler H; Ackerman SJ; Acharya KR
    Structure; 1995 Dec; 3(12):1379-93. PubMed ID: 8747464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain.
    Nagae M; Nishi N; Murata T; Usui T; Nakamura T; Wakatsuki S; Kato R
    Glycobiology; 2009 Feb; 19(2):112-7. PubMed ID: 18977853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for subsites in the galectins involved in sugar binding at the nonreducing end of the central galactose of oligosaccharide ligands: sequence analysis, homology modeling and mutagenesis studies of hamster galectin-3.
    Henrick K; Bawumia S; Barboni EA; Mehul B; Hughes RC
    Glycobiology; 1998 Jan; 8(1):45-57. PubMed ID: 9451013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-ray structure of a protease-resistant mutant form of human galectin-8 with two carbohydrate recognition domains.
    Yoshida H; Yamashita S; Teraoka M; Itoh A; Nakakita S; Nishi N; Kamitori S
    FEBS J; 2012 Oct; 279(20):3937-51. PubMed ID: 22913484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role for galectin-1 in pre-mRNA splicing.
    Vyakarnam A; Dagher SF; Wang JL; Patterson RJ
    Mol Cell Biol; 1997 Aug; 17(8):4730-7. PubMed ID: 9234729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The primary structure and carbohydrate specificity of a beta-galactosyl-binding lectin from toad (Bufo arenarum Hensel) ovary reveal closer similarities to the mammalian galectin-1 than to the galectin from the clawed frog Xenopus laevis.
    Ahmed H; Pohl J; Fink NE; Strobel F; Vasta GR
    J Biol Chem; 1996 Dec; 271(51):33083-94. PubMed ID: 8955156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue.
    Nagae M; Nishi N; Nakamura-Tsuruta S; Hirabayashi J; Wakatsuki S; Kato R
    J Mol Biol; 2008 Jan; 375(1):119-35. PubMed ID: 18005988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective recognition of mannose by the human eosinophil Charcot-Leyden crystal protein (galectin-10): a crystallographic study at 1.8 A resolution.
    Swaminathan GJ; Leonidas DD; Savage MP; Ackerman SJ; Acharya KR
    Biochemistry; 1999 Oct; 38(42):13837-43. PubMed ID: 10529229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the recognition of carbohydrates by human galectin-7.
    Leonidas DD; Vatzaki EH; Vorum H; Celis JE; Madsen P; Acharya KR
    Biochemistry; 1998 Oct; 37(40):13930-40. PubMed ID: 9760227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactulose as a novel template for anticancer drug development targeting galectins.
    Kishor C; Ross RL; Blanchard H
    Chem Biol Drug Des; 2018 Oct; 92(4):1801-1808. PubMed ID: 29888844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2.15 A crystal structure of CG-16, the developmentally regulated homodimeric chicken galectin.
    Varela PF; Solís D; Díaz-Mauriño T; Kaltner H; Gabius HJ; Romero A
    J Mol Biol; 1999 Nov; 294(2):537-49. PubMed ID: 10610778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray structure of a protease-resistant mutant form of human galectin-9 having two carbohydrate recognition domains with a metal-binding site.
    Yoshida H; Nishi N; Wada K; Nakamura T; Hirashima M; Kuwabara N; Kato R; Kamitori S
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1287-1293. PubMed ID: 28687490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding and cross-linking properties of galectins.
    Fred Brewer C
    Biochim Biophys Acta; 2002 Sep; 1572(2-3):255-62. PubMed ID: 12223273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of a monoclonal antibody able to discriminate galectin-1 from galectin-2 and galectin-3.
    Cornillot JD; Pontet M; Dupuy C; Chadli A; Caron M; Joubert-Caron R; Bourin P; Bladier D
    Glycobiology; 1998 May; 8(5):425-32. PubMed ID: 9597540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble beta-galactosyl-binding lectin (galectin) from toad ovary: crystallographic studies of two protein-sugar complexes.
    Bianchet MA; Ahmed H; Vasta GR; Amzel LM
    Proteins; 2000 Aug; 40(3):378-88. PubMed ID: 10861929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction.
    Matsushita N; Nishi N; Seki M; Matsumoto R; Kuwabara I; Liu FT; Hata Y; Nakamura T; Hirashima M
    J Biol Chem; 2000 Mar; 275(12):8355-60. PubMed ID: 10722666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity binding of recombinant human galectin-4 to SO(3)(-)-->3Galbeta1-->3GalNAc pyranoside.
    Ideo H; Seko A; Ohkura T; Matta KL; Yamashita K
    Glycobiology; 2002 Mar; 12(3):199-208. PubMed ID: 11971864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.